ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reports a Q1 loss of $0.41, 2 cents worse than estimates.

This article: 87 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE